AptarGroup : Aptar Pharma to Demonstrate its Expertise in Multi-dose Preservat...
April 19, 2019 at 10:28 am
Share
Aptar Pharma, a leading provider of drug delivery systems, services and active packaging solutions worldwide, is pleased to be a key exhibitor at ARVO 2019, taking place on April 28 - May 2 at the Vancouver Convention Center, Vancouver, Canada.
ARVO is an annual international conference, bringing together eye and vision researchers to provide the public, patients and policymakers with insight into how their sight-saving work greatly benefits society. The theme for ARVO 2019 - 'From bench to bedside and back' - will highlight the importance of the full journey that often takes place from research labs to the patient and back to the bench again, in the search for a novel treatment.
Aptar Pharma will exhibit at Booth No. 928, where we will demonstrate our expertise in the field of multi-dose preservative-free packaging for Eye Care to ARVO's 11,000 expected delegates.
With over 200 references for both prescription medications and consumer products, Aptar Pharma will have a special focus on our Preservative-free multidose Ophthalmic Squeeze Dispenser, which was recently approved for Santen's prescription treatment for glaucoma in 26 European countries.
Our versatile Ophthalmic Squeeze Dispenser Technology Platform allows for a wide range of configurations and applications, enabling customized solutions for specific ophthalmic formulations. With Aptar Pharma known for creating the first and only FDA-reviewed preservative free dispensing technology, our experts will provide delegates with insight into how we can accelerate customers' speed-to-market in line with industry standards.
To connect with Aptar Pharma and meet our team of experts, register here for ARVO 2019 today.
Attachments
Original document
Permalink
Disclaimer
AptarGroup Inc. published this content on 19 April 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 19 April 2019 14:27:02 UTC
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.